Semaglutide vs Tirzepatide: A Denver Pharmacist's Comparison

If your Denver provider has mentioned both semaglutide and tirzepatide, you are not alone in feeling confused. Both are injectable weight-management medications, both are compounded at licensed pharmacies, and both can produce meaningful results. The right choice is a clinical decision your prescriber makes, but here is what the pharmacy sees.

Mechanism: one hormone vs two

Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual GIP and GLP-1 receptor agonist, meaning it acts on two gut hormones instead of one. In head-to-head trials, tirzepatide produced greater average weight loss, though individual results always vary.

Typical results

• Semaglutide: average 10 to 15 percent body-weight reduction over 12 to 18 months.
• Tirzepatide: average 15 to 22 percent body-weight reduction over the same window.
• Both plateau: expect the biggest changes in months 3 to 9, then a slower descent.

Side effects

Both medications commonly cause nausea, constipation, and fatigue during dose escalation. Most patients tolerate the ramp better when they start low and titrate slowly, which is exactly what compounding allows us to fine-tune.

Cost

Compounded semaglutide is generally less expensive per month than compounded tirzepatide. Both are substantially less than brand-name Ozempic, Wegovy, Mounjaro, or Zepbound. Call RxByDesign at 720-507-6344 for a current quote.

Which one is right for you?

That is your provider's call. Factors include your medical history, weight-loss goals, prior GLP-1 experience, side-effect tolerance, and budget. If you do not have a Denver provider yet, we work with several weight-loss and functional-medicine clinics across the metro and can point you to prescribers accepting new patients.

How RxByDesign fits in

Once your prescription arrives, we compound to your provider's exact protocol, package with cold shipping if needed, and deliver free across the Denver metro. Refills are coordinated so you never miss a titration step.